Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & Rescheduling Efforts
Bill decriminalizing psychedelic mushrooms under review in Virginia
ABC 8 - RICHMOND, VA
A push to reduce the penalty for adult possession of psychedelic mushrooms is under review in the Virginia General Assembly.
A push to reduce the penalty for adult possession of psychedelic mushrooms is under review in the Virginia General Assembly.
Bill could open the door to legalize medical-use psychedelics in Utah
FOX 13 - SALT LAKE CITY, UT
Rep. Brady Brammer acknowledges he’s not the type to run legislation on psychedelics.
Rep. Brady Brammer acknowledges he’s not the type to run legislation on psychedelics.
Global Coalition Launches Push To Reschedule Psilocybin Under International Rules
MARIJUANA MOMENT
A new global coalition announced a new campaign on Tuesday to get psilocybin mushrooms internationally rescheduled. As the psychedelics reform movement continues to expand domestically in the U.S., the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) is seeking a worldwide policy…
A new global coalition announced a new campaign on Tuesday to get psilocybin mushrooms internationally rescheduled. As the psychedelics reform movement continues to expand domestically in the U.S., the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) is seeking a worldwide policy…
Oregon Psilocybin Services Act (M109)
How soon will it be before Oregonians can access legal therapeutic psilocybin?
KGW 8 - PORTLAND, OR
In November 2020, Oregon became the first state in the nation to legalize psilocybin, which researchers believe could help treat depression, PTSD and addiction.
In November 2020, Oregon became the first state in the nation to legalize psilocybin, which researchers believe could help treat depression, PTSD and addiction.
Right To Try
Missouri Bill Would Give Patients Right to Try Psychedelic Drugs
RIVERFRONT TIMES
A proposed Missouri bill would amend the state law that currently blocks the federal “Right to Try Act” signed under the Trump administration in 2018....
A proposed Missouri bill would amend the state law that currently blocks the federal “Right to Try Act” signed under the Trump administration in 2018....
Research, Therapy & Science
What are the potential risks of microdosing psychedelics?
LEAFLY
Microdosing psychedelics has become a popular wellness trend, but is it really that beneficial? Learn more on the science of how much you take and how often you take psychedelics.
Microdosing psychedelics has become a popular wellness trend, but is it really that beneficial? Learn more on the science of how much you take and how often you take psychedelics.
Top Federal Drug Official Says ‘Train Has Left The Station’ On Psychedelics As Reform Movement Spreads
MARIJUANA MOMENT
A top federal drug official says the “train has left the station” on psychedelics. National Institute on Drug Abuse (NIDA) Director Nora Volkow said people are going to keep using substances such as psilocybin—especially as the reform movement expands and there’s increased attention being drawn to t…
A top federal drug official says the “train has left the station” on psychedelics. National Institute on Drug Abuse (NIDA) Director Nora Volkow said people are going to keep using substances such as psilocybin—especially as the reform movement expands and there’s increased attention being drawn to t…
Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy
FORBES
Atai Life Sciences will begin testing a nonpsychedelic derivative of the compound for at-home depression treatment.
Atai Life Sciences will begin testing a nonpsychedelic derivative of the compound for at-home depression treatment.
Study Finds 65% Of Americans With Mental Health Conditions Want Access To Psychedelics
FORBES
Respondents said that if plant medicines were “proven more effective than prescription medication with fewer side effects,” 66% would try ketamine, 62% would try psilocybin, and 56% would try MDMA.
Respondents said that if plant medicines were “proven more effective than prescription medication with fewer side effects,” 66% would try ketamine, 62% would try psilocybin, and 56% would try MDMA.
Business
4 Companies To Watch Following Updates To Canada’s Special Access Program
THE DALES REPORT
Since HC made amendments to the SAP earlier this month, psychedelic companies are ready to start taking advantage of psilocybin & MDMA’s newly afforded medical accessibility.
Since HC made amendments to the SAP earlier this month, psychedelic companies are ready to start taking advantage of psilocybin & MDMA’s newly afforded medical accessibility.
World
Canada approving psychedelics for therapy is a positive step, experts say - National | Globalnews.ca
GLOBAL NEWS
Health Canada will now allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy through its Special Access Program.
Health Canada will now allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy through its Special Access Program.
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
